FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4324365148> ?p ?o ?g. }

• W4324365148 endingPage "477" @default.
• W4324365148 startingPage "466" @default.
• W4324365148 abstract "Homozygous deletion (HD) of the CDKN2A/B locus has emerged as an unfavourable prognostic marker in diffuse gliomas, both IDH-mutant and IDH-wild-type. Testing for CDKN2A/B deletions can be performed by a variety of approaches, including copy number variation (CNV) analysis based on gene array analysis, next generation sequencing (NGS) or fluorescence in situ hybridisation (FISH), but questions remain regarding the accuracy of testing modalities. In this study, we assessed: (1) the utility of S-methyl-5'-thioadenosine phosphorylase (MTAP) and cellular tumour suppressor protein pl61NK4a (p16) immunostainings as surrogate markers for CDKN2A/B HD in gliomas, and (2) the prognostic value of MTAP, across different histological tumour grades and IDH mutation status. One hundred consecutive cases of diffuse and circumscribed gliomas (Cohort 1) were collected, in order to correlate MTAP and p16 expression with the CDKN2A/B status in the CNV plot of each tumour. IDH1 R132H, ATRX and MTAP immunohistochemistry was performed on next generation tissue microarrays (ngTMAs) of 251 diffuse gliomas (Cohort 2) for implementing survival analysis. Complete loss of MTAP and p16 by immunohistochemistry was 100% and 90% sensitive as well as 97% and 89% specific for CDKN2A/B HD, respectively, as identified on CNV plot. Only two cases (2/100) with MTAP and p16 loss of expression did not demonstrate CDKN2A/B HD in CNV plot; however, FISH analysis confirmed the HD for CDKN2A/B. Moreover, MTAP deficiency was associated with shortened survival in IDH-mutant astrocytomas (n=75; median survival 61 vs 137 months; p<0.0001), IDH-mutant oligodendrogliomas (n=59; median survival 41 vs 147 months; p<0.0001) and IDH-wild-type gliomas (n=117; median survival 13 vs 16 months; p=0.011). In conclusion, MTAP immunostaining is an important complement for diagnostic work-up of gliomas, because of its excellent correlation with CDKN2A/B status, robustness, rapid turnaround time and low costs, and provides significant prognostic value in IDH-mutant astrocytomas and oligodendrogliomas, while p16 should be used cautiously." @default.
• W4324365148 created "2023-03-16" @default.
• W4324365148 creator A5018589950 @default.
• W4324365148 creator A5022871416 @default.
• W4324365148 creator A5023512209 @default.
• W4324365148 creator A5032572194 @default.
• W4324365148 creator A5035468735 @default.
• W4324365148 creator A5055449543 @default.
• W4324365148 creator A5079805537 @default.
• W4324365148 creator A5085508858 @default.
• W4324365148 date "2023-06-01" @default.
• W4324365148 modified "2023-09-27" @default.
• W4324365148 title "Evaluation of MTAP and p16 immunohistochemical deficiency as surrogate marker for CDKN2A/B homozygous deletion in gliomas" @default.
• W4324365148 cites W1969586296 @default.
• W4324365148 cites W1982067611 @default.
• W4324365148 cites W2007116705 @default.
• W4324365148 cites W2078614449 @default.
• W4324365148 cites W2146113976 @default.
• W4324365148 cites W2165301909 @default.
• W4324365148 cites W228600387 @default.
• W4324365148 cites W2293496672 @default.
• W4324365148 cites W2321587450 @default.
• W4324365148 cites W2470908168 @default.
• W4324365148 cites W2562644624 @default.
• W4324365148 cites W2789798553 @default.
• W4324365148 cites W2802818144 @default.
• W4324365148 cites W2811036728 @default.
• W4324365148 cites W2887772874 @default.
• W4324365148 cites W2894102714 @default.
• W4324365148 cites W2921106016 @default.
• W4324365148 cites W2952513725 @default.
• W4324365148 cites W3003863259 @default.
• W4324365148 cites W3023953516 @default.
• W4324365148 cites W3092871279 @default.
• W4324365148 cites W3094420447 @default.
• W4324365148 cites W3113537649 @default.
• W4324365148 cites W3116530739 @default.
• W4324365148 cites W3174246647 @default.
• W4324365148 cites W4200411223 @default.
• W4324365148 cites W4211105004 @default.
• W4324365148 doi "https://doi.org/10.1016/j.pathol.2023.01.005" @default.
• W4324365148 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37032198" @default.
• W4324365148 hasPublicationYear "2023" @default.
• W4324365148 type Work @default.
• W4324365148 citedByCount "2" @default.
• W4324365148 countsByYear W43243651482023 @default.
• W4324365148 crossrefType "journal-article" @default.
• W4324365148 hasAuthorship W4324365148A5018589950 @default.
• W4324365148 hasAuthorship W4324365148A5022871416 @default.
• W4324365148 hasAuthorship W4324365148A5023512209 @default.
• W4324365148 hasAuthorship W4324365148A5032572194 @default.
• W4324365148 hasAuthorship W4324365148A5035468735 @default.
• W4324365148 hasAuthorship W4324365148A5055449543 @default.
• W4324365148 hasAuthorship W4324365148A5079805537 @default.
• W4324365148 hasAuthorship W4324365148A5085508858 @default.
• W4324365148 hasBestOaLocation W43243651481 @default.
• W4324365148 hasConcept C104317684 @default.
• W4324365148 hasConcept C121608353 @default.
• W4324365148 hasConcept C127848430 @default.
• W4324365148 hasConcept C142724271 @default.
• W4324365148 hasConcept C143065580 @default.
• W4324365148 hasConcept C143998085 @default.
• W4324365148 hasConcept C193270364 @default.
• W4324365148 hasConcept C204232928 @default.
• W4324365148 hasConcept C2776689207 @default.
• W4324365148 hasConcept C2776750431 @default.
• W4324365148 hasConcept C2778264664 @default.
• W4324365148 hasConcept C2780265364 @default.
• W4324365148 hasConcept C501734568 @default.
• W4324365148 hasConcept C502942594 @default.
• W4324365148 hasConcept C54355233 @default.
• W4324365148 hasConcept C555283112 @default.
• W4324365148 hasConcept C71924100 @default.
• W4324365148 hasConcept C86803240 @default.
• W4324365148 hasConceptScore W4324365148C104317684 @default.
• W4324365148 hasConceptScore W4324365148C121608353 @default.
• W4324365148 hasConceptScore W4324365148C127848430 @default.
• W4324365148 hasConceptScore W4324365148C142724271 @default.
• W4324365148 hasConceptScore W4324365148C143065580 @default.
• W4324365148 hasConceptScore W4324365148C143998085 @default.
• W4324365148 hasConceptScore W4324365148C193270364 @default.
• W4324365148 hasConceptScore W4324365148C204232928 @default.
• W4324365148 hasConceptScore W4324365148C2776689207 @default.
• W4324365148 hasConceptScore W4324365148C2776750431 @default.
• W4324365148 hasConceptScore W4324365148C2778264664 @default.
• W4324365148 hasConceptScore W4324365148C2780265364 @default.
• W4324365148 hasConceptScore W4324365148C501734568 @default.
• W4324365148 hasConceptScore W4324365148C502942594 @default.
• W4324365148 hasConceptScore W4324365148C54355233 @default.
• W4324365148 hasConceptScore W4324365148C555283112 @default.
• W4324365148 hasConceptScore W4324365148C71924100 @default.
• W4324365148 hasConceptScore W4324365148C86803240 @default.
• W4324365148 hasFunder F4320310992 @default.
• W4324365148 hasIssue "4" @default.
• W4324365148 hasLocation W43243651481 @default.
• W4324365148 hasLocation W43243651482 @default.
• W4324365148 hasLocation W43243651483 @default.
• W4324365148 hasLocation W43243651484 @default.

• next